tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ARWR Stock Latest News

Arrowhead announces asset purchase agreement between Sanofi, Visirna
The FlyArrowhead announces asset purchase agreement between Sanofi, Visirna
9h ago
SNY
ARWR
Strategic Collaboration with Sarepta Boosts Arrowhead Pharmaceuticals’ Buy Rating
PremiumRatings
Strategic Collaboration with Sarepta Boosts Arrowhead Pharmaceuticals’ Buy Rating
1d ago
ARWR
Cautious Hold Rating for Arrowhead Pharmaceuticals Amid SRPT Developments and Market Uncertainties
PremiumRatings
Cautious Hold Rating for Arrowhead Pharmaceuticals Amid SRPT Developments and Market Uncertainties
2d ago
ARWR
Sarepta tells Bloomberg expects to honor Arrowhead commitments
PremiumThe Fly
Sarepta tells Bloomberg expects to honor Arrowhead commitments
4d ago
ARWR
SRPT
Arrowhead earns $100M milestone payment from Sarepta
PremiumThe Fly
Arrowhead earns $100M milestone payment from Sarepta
4d ago
ARWR
SRPT
Arrowhead issues statement on exclusive license agreement with Sarepta
PremiumThe FlyArrowhead issues statement on exclusive license agreement with Sarepta
9d ago
ARWR
SRPT
Hold Rating on Arrowhead Pharmaceuticals Amid Uncertainty in Partnership with Sarepta Therapeutics
Premium
Ratings
Hold Rating on Arrowhead Pharmaceuticals Amid Uncertainty in Partnership with Sarepta Therapeutics
10d ago
ARWR
Arrowhead falls -11.5%
Premium
The Fly
Arrowhead falls -11.5%
11d ago
ARWR
Arrowhead falls -8.9%
PremiumThe Fly
Arrowhead falls -8.9%
11d ago
ARWR
Cautious Hold Rating on Arrowhead Pharmaceuticals Amid Uncertainty in Sarepta Partnership
PremiumRatings
Cautious Hold Rating on Arrowhead Pharmaceuticals Amid Uncertainty in Sarepta Partnership
11d ago
ARWR
Arrowhead Pharmaceuticals Advances Phase 3 Study of Zodasiran for Cholesterol Management
PremiumCompany Announcements
Arrowhead Pharmaceuticals Advances Phase 3 Study of Zodasiran for Cholesterol Management
21d ago
ARWR
Arrowhead Pharmaceuticals Advances Phase 3 Study on Plozasiran for Hypertriglyceridemia
PremiumCompany Announcements
Arrowhead Pharmaceuticals Advances Phase 3 Study on Plozasiran for Hypertriglyceridemia
22d ago
ARWR
Arrowhead doses first patient in YOSEMITE trial
PremiumThe FlyArrowhead doses first patient in YOSEMITE trial
24d ago
ARWR
Arrowhead completes enrollment in SHASTA-3, SHASTA-4 and MUIR-3
Premium
The Fly
Arrowhead completes enrollment in SHASTA-3, SHASTA-4 and MUIR-3
1M ago
ARWR
Arrowhead initiates Phase 1/2a study of ARO-ALK7
Premium
The Fly
Arrowhead initiates Phase 1/2a study of ARO-ALK7
2M ago
ARWR
Arrowhead Pharmaceuticals: Strong Buy Rating Backed by Promising RNAi Pipeline and Strategic Partnerships
PremiumRatings
Arrowhead Pharmaceuticals: Strong Buy Rating Backed by Promising RNAi Pipeline and Strategic Partnerships
2M ago
ARWR
Arrowhead Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
PremiumCompany Announcements
Arrowhead Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
3M ago
ARWR
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
BMY
ABBV
Arrowhead price target lowered to $63 from $71 at UBS
PremiumThe Fly
Arrowhead price target lowered to $63 from $71 at UBS
3M ago
ARWR
Arrowhead Pharmaceuticals: Strong Financial Position with Pipeline Uncertainties Justifying Hold Rating
PremiumRatingsArrowhead Pharmaceuticals: Strong Financial Position with Pipeline Uncertainties Justifying Hold Rating
3M ago
ARWR
Arrowhead Pharmaceuticals: Hold Rating Amid Promising Developments and Regulatory Uncertainties
Premium
Ratings
Arrowhead Pharmaceuticals: Hold Rating Amid Promising Developments and Regulatory Uncertainties
3M ago
ARWR
Arrowhead price target lowered to $17 from $21 at Citi
Premium
The Fly
Arrowhead price target lowered to $17 from $21 at Citi
3M ago
ARWR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >